|
1
|
Wei F, Huang P, Li S, et al: Enhancement
patterns of gastric carcinoma on contrast-enhanced ultrasonography:
relationship with clinicopathological features. PLoS One.
8:e730502013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Paz H, Pathak N and Yang J: Invading one
step at a time: the role of invadopodia in tumor metastasis.
Oncogene. 33:4193–4202. 2014. View Article : Google Scholar
|
|
3
|
Iizasa T, Fujisawa T, Suzuki M, et al:
Elevated levels of circulating plasma matrix metalloproteinase 9 in
non-small cell lung cancer patients. Clin Cancer Res. 5:149–153.
1999.PubMed/NCBI
|
|
4
|
Hofmann UB, Westphal JR, Van Muijen GN and
Ruiter DJ: Matrix metalloproteinases in human melanoma. J Invest
Dermatol. 115:337–344. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Westermarck J and Kähäri VM: Regulation of
matrix metalloproteinase expression in tumor invasion. FASEB J.
13:781–792. 1999.PubMed/NCBI
|
|
6
|
Tan SY, Wang JY, Shen L, Luo HS and Shen
ZX: Relationship between preoperative staging by endoscopic
ultrasonography and MMP-9 expression in gastric carcinoma. World J
Gastroenterol. 13:2108–2112. 2007.PubMed/NCBI
|
|
7
|
Ylisirniö S, Höyhtyä M and
Turpeenniemi-Hujanen T: Serum matrix metalloproteinases -2, -9 and
tissue inhibitors of metalloproteinases -1, -2 in lung cancer -
TIMP-1 as a prognostic marker. Anticancer Res. 20:1311–1316.
2000.
|
|
8
|
Czyzewska J, Guzińska-Ustymowicz K, Kemona
A and Bandurski R: The expression of matrix metalloproteinase 9 and
cathepsin B in gastric carcinoma is associated with lymph node
metastasis, but not with postoperative survival. Folia Histochem
Cytobiol. 46:57–64. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zheng H, Takahashi H, Murai Y, et al:
Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth,
invasion, metastasis and angiogenesis of gastric carcinoma.
Anticancer Res. 26:3579–3583. 2006.PubMed/NCBI
|
|
10
|
Sobin LH and Fleming ID: TNM
Classification of Malignant Tumors, fifth edition (1997). Union
Internationale Contre le Cancer and the American Joint Committee on
Cancer. Cancer. 80:1803–1804. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Peng SH, Deng H, Yang JF, et al:
Significance and relationship between infiltrating inflammatory
cell and tumor angiogenesis in hepatocellular carcinoma tissues.
World J Gastroenterol. 11:6521–6524. 2005.
|
|
12
|
Endo K, Maehara Y, Baba H, et al: Elevated
levels of serum and plasma metalloproteinases in patients with
gastric cancer. Anticancer Res. 17:2253–2258. 1997.PubMed/NCBI
|
|
13
|
Alakus H, Grass G, Hennecken JK, et al:
Clinicopathological significance of MMP-2 and its specific
inhibitor TIMP-2 in gastric cancer. Histol Histopathol. 23:917–923.
2008.PubMed/NCBI
|
|
14
|
Lee KH, Shin SJ, Kim KO, et al:
Relationship between E-cadherin, matrix metalloproteinase-7 gene
expression and clinicopathological features in gastric carcinoma.
Oncol Rep. 16:823–830. 2006.PubMed/NCBI
|
|
15
|
Lee LY, Wu CM, Wang CC, et al: Expression
of matrix metalloproteinases MMP-2 and MMP-9 in gastric cancer and
their relation to claudin-4 expression. Histol Histopathol.
23:515–521. 2008.PubMed/NCBI
|
|
16
|
Papathoma AS, Petraki C, Grigorakis A, et
al: Prognostic significance of matrix metalloproteinases 2 and 9 in
bladder cancer. Anticancer Res. 20:2009–2013. 2000.PubMed/NCBI
|
|
17
|
Park KJ, Hwang SC, Sheen SS, Oh YJ, Han JH
and Lee KB: Expression of matrix metalloproteinase-9 in pleural
effusions of tuberculosis and lung cancer. Respiration. 72:166–175.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Torii A, Kodera Y, Uesaka K, et al: Plasma
concentration of matrix metalloproteinase 9 in gastric cancer. Br J
Surg. 84:133–136. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Unemori EN, Hibbs MS and Amento EP:
Constitutive expression of a 92-kD gelatinase (type V collagenase)
by rheumatoid synovial fibroblasts and its induction in normal
human fibroblasts by inflammatory cytokines. J Clin Invest.
88:1656–1662. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Creemers EE, Cleutjens JP, Smits JF and
Daemen MJ: Matrix metalloproteinase inhibition after myocardial
infarction: a new approach to prevent heart failure? Circ Res.
89:201–210. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Herman MP, Sukhova GK, Libby P, et al:
Expression of neutrophil collagenase (matrix metalloproteinase-8)
in human atheroma: a novel collagenolytic pathway suggested by
transcriptional profiling. Circulation. 104:1899–1904. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bergin PJ, Raghavan S, Svensson H, et al:
Gastric gelatinase B/matrix metalloproteinase-9 is rapidly
increased in Helicobacter felis-induced gastritis. FEMS Immunol Med
Microbiol. 52:88–98. 2008. View Article : Google Scholar
|
|
23
|
Wu CY, Wu MS, Chiang EP, et al: Plasma
matrix metalloproteinase-9 level is better than serum matrix
metalloproteinase-9 level to predict gastric cancer evolution. Clin
Cancer Res. 13:2054–2060. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dragutinović VV, Radovanović NS,
Izrael-Zivković LT and Vrvić MM: Detection of gelatinase B activity
in serum of gastric cancer patients. World J Gastroenterol.
12:105–109. 2006.
|
|
25
|
Gerlach RF, Uzuelli JA, Souza-Tarla CD and
Tanus-Santos JE: Effect of anticoagulants on the determination of
plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities. Anal
Biochem. 344:147–149. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Laack E, Scheffler A, Burkholder I, et al:
Pretreatment vascular endothelial growth factor (VEGF) and matrix
metalloproteinase-9 (MMP-9) serum levels in patients with
metastatic non-small cell lung cancer (NSCLC). Lung Cancer.
50:51–58. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shimanuki Y, Takahashi K, Cui R, et al:
Role of serum vascular endothelial growth factor in the prediction
of angiogenesis and prognosis for non-small cell lung cancer. Lung.
183:29–42. 2005. View Article : Google Scholar : PubMed/NCBI
|
